Antibiotic tolerance reduces the ability to prevent resistance under drug combination therapies

  13 January 2020

To improve patient outcomes as well as to reduce the potential for the emergence of resistance, it’s become common clinical practice to use combinations of antimicrobial drugs to treat the most serious and stubborn infections. Whereas antimicrobial resistance renders microbes invulnerable to the drugs designed to kill them, they can also become more tolerant of them, which is often associated with the failure of antibiotic treatments and the relapse of infections. Previous studies have demonstrated the rapid emergence of tolerance during single antibiotic treatments, which can subsequently promote the evolution of resistance. However, the effect of tolerance on the emergence of resistance when drug combinations are used remains unclear.

Further reading: EurekAlert
Author(s): EurekAlert
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!